# PTC Therapeutics, Inc.: Form 8-K, filed Sep 21, 2026

- Company: [PTC Therapeutics, Inc.](/companies/ptct.md) (CIK 1070081)
- Form: 8-K
- Filed: 2026-09-21
- Accepted by EDGAR: Sep 21, 2026, 16:34 ET
- Period: 2026-09-21
- Accession: 0001070081-26-000023
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1070081/000107008126000023/tmb-20260921x8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1070081/000107008126000023/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1070081/000107008126000023/tmb-20260921x8k.htm

Filed Sep 21, 2026.
Source: SEC EDGAR, the filing index for accession 0001070081-26-000023. Last ingested by Listed: Nov 10, 2026, 17:24 ET. No prices; not investment advice.
